Senescent cells as a source of inflammatory factors for tumor progression
Open accessThe DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Cellular senescence, which is associated with aging, is a process by which cells enter a state of permanent cell cycle arrest, therefore constituting a potent tumor suppressive mechanism. Recent studies show that, despite the beneficial effects of cellular senescence, senescent cells can also exert harmful effects on the tissue microenvironment. The most significant of these effects is the acquisition of a senescent-associated secretory phenotype (SASP), which entails a striking increase in the secretion of pro-inflammatory cytokines. Here, we summarize our knowledge of the SASP and the impact it has on tissue microenvironments and ability to stimulate tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“KRAS constitutively activates NF-kB and drives the expression of cytokines that belong to SASP, with the most prominent cytokine being secreted being IL-6 (28).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“many SASP components directly or indirectly promote inflammation (59, 92, 93, 107, 108).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [107]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The secretion of these and similar proteins by senescent cells is predicted to cause chronic inflammation, at least locally and possibly systemically (91–93, 107).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [107]
Experimental — accuracy not yet measuredIn the citing paper
“However, NF-κB dependent pro-inflammatory factors are the key components of SASP with IL-6 and IL-8 being the most conserved and robustly expressed cytokines (Hardy et al., 2005; Davalos et al., 2010; Freund et al., 2010; Soto-Gamez and Demaria, 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Davalos et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Lodish, H. F. (1986) · Cited by 5,650
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Self-citationNuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Self-citationMitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317 · cited 2×
“In addition, blockage of IL-1 receptor signaling prevented upregulation of miR-146a/b, consistent with these microRNAs being part of an NF-κB feedback loop [83].”
BackgroundRelease of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 1×
“The discovery that necrotic cells, but not apoptotic cells, passively release HMGB1 focused recent studies on the role of extracellular HMGB1 [90].”
BackgroundA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“Consequently, with each cell cycle, telomeres shorten and eventually fail, generating a persistent DNA damage signal that permanently arrests growth [27].”
BackgroundMet, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 2×
“This notion is consistent with two studies that suggest senescent cells may undergo clearance in vivo [13, 97].”
BackgroundResultSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Senescent cells are detected in culture and in vivo by a variety of markers, including the senescence-associated β-galactosidase (SAβgal) [28], p16 [39], telomere-associated DNA damage foci [40], senescence-associated heterochromatin foci [41], and several other molecules; all of these markers have some limitations, a…”
BackgroundPersistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Self-citationBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Self-citationNucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654 · cited 1×
“Similar to recent data showing that apoptotic cells release “find-me signals”, which recruit innate immune to clear the dying cells, senescent cells also secrete HMGB1, known to recruit and activate cells from the innate immune system [96].”
ResultInk4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 1×
“Senescent cells are detected in culture and in vivo by a variety of markers, including the senescence-associated β-galactosidase (SAβgal) [28], p16 [39], telomere-associated DNA damage foci [40], senescence-associated heterochromatin foci [41], and several other molecules; all of these markers have some limitations, a…”
BackgroundHorder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“Senescent cells are detected in culture and in vivo by a variety of markers, including the senescence-associated β-galactosidase (SAβgal) [28], p16 [39], telomere-associated DNA damage foci [40], senescence-associated heterochromatin foci [41], and several other molecules; all of these markers have some limitations, a…”
BackgroundThe signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 1×
“Many types of stresses can provoke cellular senescence [5, 29] (see Fig.”
BackgroundThe common biology of cancer and ageing
Finkel, T., Serrano, M., & Blasco, M. A. (2007) · Nature · doi:10.1038/nature05985 · Cited by 988 · cited 1×
“These molecules can enhance cancer cell aggressiveness, as well as promote aging and age-related degeneration [70, 71].”
BackgroundDePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
DNA Repair, Genome Stability, and Aging
Lombard, D. B., Chua, K. F., Mostoslavsky, R., Franco, S., Gostissa, M., & Alt, F. W. (2005) · Cell · doi:10.1016/j.cell.2005.01.028 · Cited by 944
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 1×
“Further, virtually all cancers harbor mutations in the p53 and/or p16/ pRB pathways, which, among other activities, are crucial for the senescence response [8, 9].”
BackgroundPharmacological Rescue of Mutant p53 Conformation and Function
Foster, B. A., Coffey, H. A., Morin, M. J., & Rastinejad, F. (1999) · Science · doi:10.1126/science.286.5449.2507 · Cited by 799
Inhibiting the p53–MDM2 interaction: an important target for cancer therapy
Chène, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc991 · Cited by 765
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · cited 1×
“allow cells to ignore certain senescence-inducing signals and greatly increase cancer susceptibility [6, 7].”
BackgroundRas Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species
Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., Yu, Z.-X., Ferrans, V. J., Howard, B. H., & Finkel, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7936 · Cited by 691
Enhanced Peroxynitrite Formation Is Associated with Vascular Aging
van der Loo, B., Labugger, R., Skepper, J. N., Bachschmid, M., Kilo, J., Powell, J. M., Palacios-Callender, M., Erusalimsky, J. D., Quaschning, T., Malinski, T., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1731 · Cited by 675
Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654
Self-citationArterial Aging: Is It an Immutable Cardiovascular Risk Factor?
Najjar, S. S., Scuteri, A., & Lakatta, E. G. (2005) · Hypertension · doi:10.1161/01.hyp.0000177474.06749.98 · Cited by 640
Parrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631 · cited 11×
“3.2 Secreted proteases Aside from soluble signaling cytokines and growth factors, senescent cells also secrete increased levels of some matrix metalloproteinases (MMPs).”
BackgroundSelf-citationMcQuibban, G. A., Gong, J.-H., Wong, J. P., Wallace, J. L., Clark-Lewis, I., & Overall, C. M. (2002) · Blood · doi:10.1182/blood.v100.4.1160.h81602001160_1160_1167 · Cited by 611
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence
Coppé, J.-P., Kauser, K., Campisi, J., & Beauséjour, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603307200 · Cited by 604 · cited 5×
“Endothelial cells can undergo proliferation during angiogenesis, which is stimulated by vascular endothelial growth factor (VEGF), IL-8, I-309, and eotaxin [44, 116, 117], all of which are SASP components.”
BackgroundSelf-citationHiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., & Bensi, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6231 · Cited by 585
Accumulation of senescent cells in Mitotic tissue of aging primates
Jeyapalan, J. C., Ferreira, M., Sedivy, J. M., & Herbig, U. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.008 · Cited by 571 · cited 2×
“Consistent with a role in aging, senescent cells accumulate with age in many rodent, non-human primate, and human tissues [14, 15].”
BackgroundBarcellos‐Hoff, M. H., & Ravani, S. A. (2000) · PubMed · Cited by 536
HMG proteins: dynamic players in gene regulation and differentiation
Bianchi, M. E., & Agresti, A. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.08.007 · Cited by 521
Cancer and ageing: rival demons?
Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512 · cited 1×
“However, because these mechanisms are imperfect, cancer still poses a major challenge to the longevity of such organisms [1, 2].”
BackgroundSelf-citationHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Orjalo, A. V., Rodier, F., Lithgow, G. J., & Campisi, J. (2009) · Aging · doi:10.18632/aging.100042 · Cited by 500 · cited 6×
“As discussed below, IL-6 and IL-8 expressions depend on the expression and secretion of IL-1α, indicating a hierarchy on how SASP components are regulated.”
BackgroundSelf-citationLiu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499
RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages
Kokkola, R., Andersson, Å., Mullins, G., Östberg, T., Treutiger, C. ‐., Arnold, B., Nawroth, P., Andersson, U., Harris, R. A., & Harris, H. E. (2005) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2005.01534.x · Cited by 496
Senescence-Associated Exosome Release from Human Prostate Cancer Cells
Lehmann, B. D., Paine, M. S., Brooks, A. M., McCubrey, J. A., Renegar, R. H., Wang, R., & Terrian, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6538 · Cited by 464
Coppé, J.-P., Patil, C. K., Rodier, F., Krtolica, A., Beauséjour, C. M., Parrinello, S., Hodgson, J. G., Chin, K., Desprez, P.-Y., & Campisi, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009188 · Cited by 455 · cited 4×
“Recent studies on the senescence-associated secretory phenotype (SASP) of human and mouse fibroblasts show it is conserved across cell types and species and that specific secreted factors are strong candidates for stimulating malignant phenotypes in neighboring cells [22, 23].”
BackgroundSelf-citationBavik, C., Coleman, I., Dean, J. P., Knudsen, B., Plymate, S., & Nelson, P. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1716 · Cited by 453 · cited 1×
“Fibroblasts from the human prostate gland that undergo senescence in culture have been shown to create a local tissue environment that favors prostate epithelial cell hyperproliferation, in part owing to amphiregulin secretion [20].”
BackgroundActivation of gene expression in human neutrophils by high mobility group box 1 protein
Park, J. S., Arcaroli, J., Yum, H.-K., Yang, H., Wang, H., Yang, K.-Y., Choe, K.-H., Strassheim, D., Pitts, T. M., Tracey, K. J., et al. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00322.2002 · Cited by 433
Bianchi, M. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008585 · Cited by 416
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
Schadendorf, D., Möller, A., Algermissen, B., Worm, M., Sticherling, M., & Czarnetzki, B. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2667 · Cited by 412
Cancer CXC chemokine networks and tumour angiogenesis
Strieter, R. M., Burdick, M. D., Mestas, J., Gomperts, B., Keane, M. P., & Belperio, J. A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.006 · Cited by 410
The power and the promise of oncogene-induced senescence markers
Collado, M., & Serrano, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1884 · Cited by 404
When cells get stressed: an integrative view of cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420663 · Cited by 404 · cited 1×
“Many types of stresses can provoke cellular senescence [5, 29] (see Fig.”
BackgroundChemokines: agents for the immunotherapy of cancer?
Homey, B., Müller, A., & Zlotnik, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri748 · Cited by 398
Extension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense Oligomer
Maier, J. A. M., Voulalas, P., Roeder, D., & Maciag, T. (1990) · Science · doi:10.1126/science.2218499 · Cited by 397
HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
Sha, Y., Zmijewski, J., Xu, Z., & Abraham, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2531 · Cited by 393
Cellular senescence as a tumor-suppressor mechanism
Campisi, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82148-6 · Cited by 390
Self-citationOhuchida, K., Mizumoto, K., Murakami, M., Qian, L.-W., Sato, N., Nagai, E., Matsumoto, K., Nakamura, T., & Tanaka, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2464 · Cited by 384
Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence
Macip, S., Igarashi, M., Fang, L., Chen, A., Pan, Z., Lee, S. W., & Aaronson, S. A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2180 · Cited by 374
Molecular basis of angiogenesis and cancer
Tonini, T., Rossi, F., & Claudio, P. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206816 · Cited by 347
Selivanova, G., Iotsova, V., Okan, I., Fritsche, M., Ström, M., Groner, B., Grafström, R. C., & Wiman, K. G. (1997) · Nature Medicine · doi:10.1038/nm0697-632 · Cited by 343
BENBARUCH, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 335
Potempa, S., & Ridley, A. J. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.8.2185 · Cited by 327
Kokkola, R., Li, J., Sundberg, E., Aveberger, A. ‐., Palmblad, K., Yang, H., Tracey, K. J., Andersson, U., & Harris, H. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11161 · Cited by 325
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
PRAK Is Essential for ras-Induced Senescence and Tumor Suppression
Sun, P., Yoshizuka, N., New, L., Moser, B. A., Li, Y., Liao, R., Xie, C., Chen, J., Deng, Q., Yamout, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.050 · Cited by 321 · cited 1×
“These effects have been observed with a number of cell types, including cells derived from breast [18, 19, 21, 22, 104], skin [105], prostate [22, 106], pancreas [107], and oro-pharyngial mucosa [108].”
BackgroundHigh mobility group protein-1 (HMG-1) is a unique activator of p53
Jayaraman, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., & Prives, C. (1998) · Genes & Development · doi:10.1101/gad.12.4.462 · Cited by 321
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602599 · Cited by 312
Cellular senescence as a tumor-protection mechanism: the essential role of counting
Wright, W. E., & Shay, J. W. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00163-5 · Cited by 306
Role of CXCL1 in tumorigenesis of melanoma
Dhawan, P., & Richmond, A. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.9 · Cited by 303
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 9×
“These effects have been observed with a number of cell types, including cells derived from breast [18, 19, 21, 22, 104], skin [105], prostate [22, 106], pancreas [107], and oro-pharyngial mucosa [108].”
BackgroundInfluentialSelf-citationKunieda, T., Minamino, T., Nishi, J.-I., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.626606 · Cited by 302
Senescence, apoptosis and therapy — cutting the lifelines of cancer
Schmitt, C. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1044 · Cited by 295
Yang, F., Tuxhorn, J. A., Ressler, S. J., McAlhany, S. J., Dang, T. D., & Rowley, D. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1702 · Cited by 278
The p16INK4a-RB pathway : molecular link between cellular senescence and tumor suppression
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2004) · The Journal of Medical Investigation · doi:10.2152/jmi.51.146 · Cited by 276 · cited 1×
“Further, virtually all cancers harbor mutations in the p53 and/or p16/ pRB pathways, which, among other activities, are crucial for the senescence response [8, 9].”
BackgroundOncogene-Induced Senescence: Putting the Brakes on Tumor Development
Braig, M., & Schmitt, C. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4006 · Cited by 274
Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen, K. A., Moses, M. A., Beecken, W.-D. C., Khan, M. K., Folkman, J., & O’Reilly, M. S. (2001) · PubMed · Cited by 261
Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells
Salcedo, R., Young, H. A., Ponce, M. L., Ward, J. M., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7571 · Cited by 257
West, M. D., Pereira-Smith, O. M., & Smith, J. R. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90372-8 · Cited by 241
Millis, A. J. T., Hoyle, M., McCue, H. M., & Martini, H. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90286-h · Cited by 239
Nesbit, M., Schaider, H., Miller, T. H., & Herlyn, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6483 · Cited by 235
Angiogenetic Signaling through Hypoxia
Schlueter, C., Weber, H., Meyer, B., Rogalla, P., Röser, K., Hauke, S., & Bullerdiek, J. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62344-9 · Cited by 229
Aging, Longevity, Inflammation, and Cancer
CARUSO, C., LIO, D., CAVALLONE, L., & FRANCESCHI, C. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.001 · Cited by 218
Young, A. R. J., & Narita, M. (2009) · The EMBO Reports · doi:10.1038/embor.2009.22 · Cited by 214 · cited 2×
“We particularly emphasize the potential effects of the SASP [25] on cell behavior in the context of tumor progression.”
BackgroundAnalysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin)
Rouhiainen, A., Tumova, S., Valmu, L., Kalkkinen, N., & Rauvala, H. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306200 · Cited by 214
Reactivation of mutant p53: molecular mechanisms and therapeutic potential
Selivanova, G., & Wiman, K. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210295 · Cited by 186
Adams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 176
Choi, J., Shendrik, I., Peacocke, M., Peehl, D., Buttyan, R., Ikeguchi, E. F., Katz, A. E., & Benson, M. C. (2000) · Urology · doi:10.1016/s0090-4295(00)00538-0 · Cited by 173
Genetic Modulation of Senescent Phenotypes in Homo sapiens
Martin, G. M. (2005) · Cell · doi:10.1016/j.cell.2005.01.031 · Cited by 171
Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8
Schaider, H., Oka, M., Bogenrieder, T., Nesbit, M., Satyamoorthy, K., Berking, C., Matsushima, K., & Herlyn, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10775 · Cited by 169
Cellular senescence and chromatin structure
Funayama, R., & Ishikawa, F. (2007) · Chromosoma · doi:10.1007/s00412-007-0115-7 · Cited by 169
Qian, L.-W., Mizumoto, K., Urashima, T., Nagai, E., Maehara, N., Sato, N., Nakajima, M., & Tanaka, M. (2002) · PubMed · Cited by 166
Regulation of cell migration by amphoterin
Fages, C., Nolo, R., Huttunen, H. J., Eskelinen, E.-L., & Rauvala, H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.4.611 · Cited by 166
Paumelle, R., Tulashe, D., Kherrouche, Z., Plaza, S., Leroy, C., Reveneau, S., Vandenbunder, B., & Fafeur, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205297 · Cited by 158
Chien, K. R., & Karsenty, G. (2005) · Cell · doi:10.1016/j.cell.2005.02.006 · Cited by 150
Cellular senescence in the pathogenesis of benign prostatic hyperplasia
Castro, P., Giri, D., Lamb, D., & Ittmann, M. (2003) · The Prostate · doi:10.1002/pros.10204 · Cited by 148
Tsai, K. K. C., Chuang, E. Y.-Y., Little, J. B., & Yuan, Z.-M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0703 · Cited by 145
Kumar, S., Millis, A. J., & Baglioni, C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4683 · Cited by 138
Sato, I., Morita, I., Kaji, K., Ikeda, M.-A., Nagao, M., & Murota, S. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2153 · Cited by 136
Cytokine expression in chronic inflammatory disease
Brennan, F. M., Maini, R. N., & Feldmann, M. (1995) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072967 · Cited by 115
Involvement of the INK4a/Arf gene locus in senescence
Collins, C. J., & Sedivy, J. M. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00048.x · Cited by 113
Subtractive Hybridization of mRNA from early passage and senescent endothelial cells
Grillari, J., Hohenwarter, O., Grabherr, R. M., & Katinger, H. W. D. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00080-2 · Cited by 105
Effects of MGSA/GRO alpha on melanocyte transformation.
Balentien, E., Mufson, B. E., Shattuck, R. L., Derynck, R., & Richmond, A. J. (1991) · PubMed · Cited by 102
Niu, J., Li, Z., Peng, B., & Chiao, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309789200 · Cited by 102
Unregulated inflammation shortens human functional longevity
Brod, S. A. (2000) · Inflammation Research · doi:10.1007/s000110050632 · Cited by 102
Alterations to Nuclear Architecture and Genome Behavior in Senescent Cells
MEHTA, I. S., FIGGITT, M., CLEMENTS, C. S., KILL, I. R., & BRIDGER, J. M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.027 · Cited by 96
Cellular senescence and chromatin organisation
Narita, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603636 · Cited by 95
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo
Bernardini, G., Spinetti, G., Ribatti, D., Camarda, G., Morbidelli, L., Ziche, M., Santoni, A., Capogrossi, M. C., & Napolitano, M. (2000) · Blood · doi:10.1182/blood.v96.13.4039 · Cited by 93
Myeloid suppressor cells regulate the adaptive immune response to cancer
Frey, A. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29906 · Cited by 93
Lu, S.-Y., Chang, K.-W., Liu, C.-J., Tseng, Y.-H., Lu, H.-H., Lee, S.-Y., & Lin, S.-C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi357 · Cited by 91
High-Affinity Binding of Tumor-Suppressor Protein p53 and HMGB1 to Hemicatenated DNA Loops
Štros, M., Muselíková-Polanská, E., Pospíšilová, Š., & Strauss, F. (2004) · Biochemistry · doi:10.1021/bi049928k · Cited by 81
Tumor Cell Interactions With the Microvasculature
Orr, F. W., & Wang, H. H. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30070-x · Cited by 76
Coppe, J.-P., Boysen, M., Sun, C. H., Wong, B. J. F., Kang, M. K., Park, N.-H., Desprez, P.-Y., Campisi, J., & Krtolica, A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0062 · Cited by 76
Self-citationGarfinkel, S., Brown, S., Wessendorf, J. H., & Maciag, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1559 · Cited by 75
Human Polynucleotide Phosphorylase ( hPNPase old-35 )
Sarkar, D., Lebedeva, I. V., Emdad, L., Kang, D.-C., Baldwin, A. S., & Fisher, P. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1772 · Cited by 72
Proteolyzed matrix as a template for the regulation of tumor progression
Hornebeck, W., & Maquart, F. X. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00049-0 · Cited by 70
Xin, M., Zhang, J., Block, E. R., & Patel, J. M. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00163-5 · Cited by 69
Kim, K., Park, G., Lim, Y.-B., Rue, S.-W., Jung, J., Sonn, J., Bae, Y., Park, J., & Lee, Y. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.108 · Cited by 67
Nickoloff, B. J., Lingen, M. W., Chang, B.-D., Shen, M., Swift, M., Curry, J., Bacon, P., Bodner, B., & Roninson, I. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2388 · Cited by 67
Dilley, T. K., Bowden, G. T., & Chen, Q. M. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00308-2 · Cited by 64 · cited 1×
“In the skin, unidentified factors secreted by human fibroblasts were shown to be capable of inducing clonal expansion of keratinocytes [112].”
BackgroundPalmieri, D., Watson, J. M., & Rinehart, C. A. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4341 · Cited by 60
Lopez-Bermejo, A. (2000) · Endocrinology · doi:10.1210/en.141.11.4072 · Cited by 57
Zeng, G., & Millis, A. J. T. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0019 · Cited by 51
Immunological Functions of Aged Human Monocytes
McLachlan, J. A., Serkin, C. D., Money-Clark, K. M., & Bakouche, O. (1995) · Pathobiology · doi:10.1159/000163946 · Cited by 50
Characterization Of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts
Wang, S. (1996) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(96)01814-3 · Cited by 41
Asymmetric dimethylarginine (ADMA) accelerates cell senescence
Bode-Böger, S. M., Scalera, F., & Martens-Lobenhoffer, J. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000110 · Cited by 40
Remodeling chromatin for senescence.
Adams, P. D. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00313.x · Cited by 37
Mantovani, A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.010 · Cited by 37
Cited by
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
“Moreover, K-Rras activation enhances production of cytokines and chemokines that belong to “senescenceassociated secretory phenotype” (Davalos et al., 2010), including IL-1α, IL-1β, CCL2 and CXCL1.”
BackgroundAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Self-citationOxidative Stress, Prooxidants, and Antioxidants: The Interplay
Rahal, A., Kumar, A., Singh, V., Yadav, B., Tiwari, R., Chakraborty, S., & Dhama, K. (2014) · BioMed Research International · doi:10.1155/2014/761264 · Cited by 1,706
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160
Self-citation
Metadata
- Authors
- Davalos, A. R., Coppe, J.-P., Campisi, J., & Desprez, P.-Y.
- Affiliations
- Buck Institute for Research on Aging (US)
- Corresponding author
- Desprez, Pierre-Yves
- Venue
- Cancer and Metastasis Reviews
- Published
- 2010-04-13
- Volume
- 29
- Issue
- 2
- Pages
- 273-283
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- PMC
- PMC2865636
- OpenAlex
- W2050852029
- Cited by
- 636
- References
- 144
- Citations by year
- 2026: 19 · 2025: 37 · 2024: 34 · 2023: 44 · 2022: 42 · 2021: 50 · 2020: 35 · 2019: 45 · 2018: 54 · 2017: 48 · 2016: 40 · 2015: 50 · 2014: 38 · 2013: 32 · 2012: 32
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Cancer and Metastasis Reviews (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion, other-oa)
- Funders
- U.S. Department of Energy (AC03-76SF00098)
- Larry L. Hillblom Foundation
- National Institutes of Health (AG09909, AG017242, AG025708, AG025901)
- National Institute on Aging (R56AG009909, AG017242, RL1AG032117, AG-09909, P01AG025901, R37AG009909, P30AG025708, AG032117, AG025708, P01AG017242, AG025901)
- National Cancer Institute (CA12654)
- National Institute of Environmental Health Sciences (ES015566)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cellular senescence, senescence-associated secretory phenotype, tumor progression, inflammatory cytokines, tumor microenvironment, aging, tumor suppression
- MeSH terms
- Animals, Humans, Inflammation, Neoplasms, Cytokines, Cellular Senescence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.